About NephroPlus
NephroPlus is a company based in Hyderabad (India) founded in 2009 by Pullaiah Vuppala, Vikram Vuppala, and Kamal D Shah. NephroPlus has raised $205.37 million across 13 funding rounds from investors including Bessemer Venture Partners, International Finance Corporation and Asian Development Bank. The company has 1,707 employees as of February 21, 2025. NephroPlus has completed 3 acquisitions, including DaVita India, Royal Care Dialysis Center and royalcaredialysis.com. NephroPlus offers products and services including In-Clinic Dialysis, Dialysis on Call, Home Hemodialysis, Holiday Dialysis, and Dialysis on Wheels. NephroPlus operates in a competitive market with competitors including DCDC, Apex Kidney Care, VitusCare, The Renal Project and Sparsh Nephrocare, among others.
- Headquarter Hyderabad, India
- Employees 1707 as on 21 Feb, 2025
- Founders Pullaiah Vuppala, Vikram Vuppala, Kamal D Shah
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nephrocare Health Services Limited
-
Annual Revenue
$39.58 M (USD)12.64as on Mar 31, 2022
-
Net Profit
-$2.58 M (USD)-3585.11as on Mar 31, 2022
-
EBITDA
$1.95 M (USD)-56.88as on Mar 31, 2022
-
Total Equity Funding
$205.37 M (USD)
in 13 rounds
-
Latest Funding Round
$103 M (USD), Series F
May 03, 2024
-
Investors
Bessemer Venture Partners
& 24 more
-
Employee Count
1707
as on Feb 21, 2025
-
Investments & Acquisitions
DaVita India
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NephroPlus
NephroPlus is a publicly listed company on the NSE with ticker symbol NEPHROPLUS in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of NephroPlus
NephroPlus offers a comprehensive portfolio of products and services, including In-Clinic Dialysis, Dialysis on Call, Home Hemodialysis, Holiday Dialysis, and Dialysis on Wheels.
Provides safe dialysis in clinical settings for kidney patients.
Offers convenient, on-demand dialysis at any location.
Delivers dialysis care directly in patients' homes.
Supports dialysis during travel at various destinations.
Provides mobile dialysis for easy access anywhere.
People of NephroPlus
Unlock access to complete
Unlock access to complete
Funding Insights of NephroPlus
NephroPlus has successfully raised a total of $205.37M across 13 strategic funding rounds. The most recent funding activity was a Series F round of $103 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NephroPlus
NephroPlus has secured backing from 25 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Bessemer Venture Partners, International Finance Corporation and Asian Development Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare private equity investments focused on Asian markets.
|
Locked | Locked | Locked | |
|
Private equity, real estate, and credit investments are managed globally.
|
Locked | Locked | Locked | |
|
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
|
Locked | Locked | Locked |
Investor details for NephroPlus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NephroPlus
NephroPlus has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include DaVita India, Royal Care Dialysis Center and royalcaredialysis.com.
Investment portfolio details for NephroPlus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Dialysis services are offered in Talisay, Philippines.
|
Locked | Locked | 2019 | Locked | |
|
Chain of dialysis clinics
|
Locked | Locked | 2013 | Locked | |
|
Provider of online medication information and resources. It offers detailed information on various medications, including uses, prices, composition, side effects, and dosages. The platform aims to empower individuals to make informed healthcare decisions by providing accessible and accurate medical details. It serves patients, caregivers, and healthcare professionals, supporting their health choices with reliable and concise information. The platform includes editorial and fact-checking policies to ensure accuracy and completeness.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for NephroPlus
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NephroPlus
Detailed financials for NephroPlus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nephroplus Comparisons
Peer comparison for NephroPlus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NephroPlus
NephroPlus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DCDC, Apex Kidney Care, VitusCare, The Renal Project and Sparsh Nephrocare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chain of dialysis and kidney clinics
|
|
| Locked | Locked | Locked |
Chain of dialysis clinics
|
|
| Locked | Locked | Locked |
Chain of dialysis clinics
|
|
| Locked | Locked | Locked |
Chain of dialysis clinics
|
|
| Locked | Locked | Locked |
Chain of dialysis clinics
|
Detailed competitors of NephroPlus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nephroplus
Complete news archive for NephroPlus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NephroPlus
NephroPlus was founded in 2009 and raised its 1st funding round 1 year after it was founded.
NephroPlus is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Rohit Singh is the current CEO of NephroPlus.
NephroPlus is a funded company, having raised a total of $205.37M across 13 funding rounds to date.
As of Feb 21, 2025, the latest employee count at NephroPlus is 1,707.
Annual revenue of NephroPlus is $39.58M as on Mar 31, 2022.
NephroPlus was founded in 2009 in Hyderabad, India, as a provider in the healthcare sector focused on dialysis. Services are delivered through in-clinic, at-home, and mobile formats to support patients with kidney disease. A training academy is maintained for dialysis technicians and nurses. Educational resources and support programs are extended to enhance patient management of chronic conditions. Operations are centered in India with an emphasis on clinical standards.
NephroPlus's top competitors include DCDC, Apex Kidney Care and VitusCare.
NephroPlus offers In-Clinic Dialysis, Dialysis on Call, Home Hemodialysis, Holiday Dialysis, and Dialysis on Wheels.
Yes, NephroPlus is publicly traded on NSE under the ticker symbol NEPHROPLUS.
NephroPlus has made 3 acquisitions, including DaVita India, Royal Care Dialysis Center, and royalcaredialysis.com.
NephroPlus has 25 investors. Key investors include Bessemer Venture Partners, International Finance Corporation, Asian Development Bank, 360 One, and Quadria Capital.
The ticker symbol of NephroPlus is NEPHROPLUS on NSE.
The valuation of NephroPlus is $236.37M as of Dec 2021.